Skip to main content
. 2020 Jan 9;23(1):49–62. doi: 10.5223/pghn.2020.23.1.49

Table 5. Comparison between Korean patients with and without perianal fistulizing disease at diagnosis.

Variable Perianal fistulizing disease p-value
Present (n=108) Absent (n=133)
Male 79 (73.1) 77 (57.9) 0.020
Age at diagnosis (yr) 14.6 (12.2–15.9) 12.5 (13.0–16.2) 0.586
1st degree family history of IBD 2 (1.9) 9 (6.8) 0.132
Previous bowel resection history 1 (0.9) 3 (2.3) 0.767
Height z-score −0.3±1.0 −0.4±1.2 0.503
Weight z-score −0.7±1.3 −1.1±1.3 0.036
BMI z-score −0.7 (−1.6–0.0) −1.2 (−2.1–−0.3) 0.009
LGI tract location 0.222
No involvement 0 (0.0) 2 (1.5)
L1 12 (11.1) 24 (18.0)
L2 10 (9.3) 14 (10.5)
L3 86 (79.6) 93 (69.9)
UGI tract location 0.076
No involvement 42 (38.9) 56 (42.1)
L4a 34 (31.5) 27 (20.3)
L4b 18 (16.7) 37 (27.8)
L4ab 14 (13.0) 13 (9.8)
Luminal disease behavior 0.828
B1 92 (85.2) 116 (87.2)
B2 13 (12.0) 14 (10.5)
B3/B2B3 3 (2.8) 3 (2.3)

Values are presented as number (%), median (interquartile range), or mean±standard deviation.

IBD: inflammatory bowel disease, BMI: body mass index, LGI: lower gastrointestinal, UGI: upper gastrointestinal, L1: distal 1/3 ileum±limited cecal disease, L2: colonic disease, L3: ileocolonic disease, L4a: upper disease proximal to the ligament of Treitz, L4b: upper disease distal to the ligament of Treitz and proximal to the distal 1/3 ileum, L4ab: upper disease involvement in both L4a and L4b, B1: nonstricturing nonpenetrating behavior, B2: stricturing behavior, B3: penetrating behavior, B2B3: both B2 and B3.